The predictive value of ERG protein expression for development of castration-resistant prostate cancer in hormone-naïve advanced prostate cancer treated with primary androgen deprivation therapy-Reference-Cited by-同舟云学术

The predictive value of ERG protein expression for development of castration-resistant prostate cancer in hormone-naïve advanced prostate cancer treated with primary androgen deprivation therapy

Published:2015-06-05 Issue:14 Volume:75 Page:1499-1509
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Berg Kasper D.¹,Røder Martin A.¹,Thomsen Frederik B.¹,Vainer Ben²,Gerds Thomas A.³,Brasso Klaus¹,Iversen Peter¹

Affiliation:

1. Copenhagen Prostate Cancer Center; Department of Urology; Rigshospitalet; University of Copenhagen; Copenhagen Denmark

2. Department of Pathology; Rigshospitalet; University of Copenhagen; Copenhagen Denmark

3. Department of Biostatistics; University of Copenhagen; Copenhagen Denmark

Funder

University of Copenhagen

Fondation Juchum

Harboefonden

Michaelsen Fonden

Rigshospitalet's Research Committee

The Scandinavian Prostate Cancer Group

Publisher

Wiley

Subject

Urology,Oncology

Reference38 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Studies on prostatic cancer: II. The effects of castration on advanced carcinoma of the prostate gland;Huggins;Arch Surg,1941

3. Mechanisms of androgen-refractory prostate cancer;Debes;N Engl J Med,2004

4. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer;Tomlins;Science,2005

5. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions;Cerveira;Neoplasia,2006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Benefit of Combining Docetaxel with Androgen Deprivation Therapy in Localized and Metastatic Hormone-sensitive Prostate Cancer is Predicted by ERG Expression: An Analysis of Two GETUG Phase 3 Trials;European Urology Oncology;2024-07

2. Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review;Cancer Cell International;2020-08-26

3. AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy;Diagnostics;2020-07-27

4. Extracellular vesicles in urological malignancies: an update;Nature Reviews Urology;2019-12-11

5. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies;Expert Review of Molecular Diagnostics;2019-09-18